The 

[1. Site Name] site [3. makes number of doses] of [2. name of product or product

type] per year. It will [4. receive XX million dollars in investment] as part of [5. the Blah
Blah initiative], a [a. partnership] with [b. Other Company]. It is a [6.Center of
Excellence] and home to the [7.Key Leader].  
!!!<<<SPACE>>>!!! 
[8. a The building was built in x year, for y reason], and has [b. these features and
certifications.] [c. It exists within a context of these other buildings that do these other
things that we may or may not care about.]  

The Anhui Anke Biotechnology (Group) Co., Ltd site [3. makes number of doses] of

Recombinant Human Growth Hormone (Ansomone®), Series of Recombinant Human
Interferon alpha 2b (Anterferon®), MAR Kit for Anti-sperm Antibody per year. It will [4. receive
XX million dollars in investment] as part of [5. the Blah Blah initiative], a [a. partnership] with
[b. Other Company]. It is a [6.Center of Excellence] and home to the [7.Key Leader].  

!!!<<<SPACE>>>!!! 
[8. a The building was built in x year, for y reason], and has [b. these features and
certifications.] [c. It exists within a context of these other buildings that do these other
things that we may or may not care about.]  
 

Anhui Anke Biotechnology (Group) Co., Ltd., is located in Hefei, China. It is a certified by GMP
and ISO9001 facility, also professional and comprehensive in developing, producing and
marketing pharmaceuticals concerning genetic engineering products, diagnostic products,
precision medicine, polypeptide APIs, biochemistry and traditional Chinese medicines. Based
on high-efficient Research & Development Centers as its subsidiary companies with dominant
products as: Recombinant Human Growth Hormone (Ansomone®), Series of Recombinant
Human Interferon alpha 2b (Anterferon®), MAR Kit for Anti-sperm Antibody. In April 2018,
Hefei high-tech zone was included in the list of world-class high-tech parks by the Torch Center
of the Ministry of Science and Technology, enabling it to enter the national team participating
in global technology competitions. By 2035, the zone is expected to be at the forefront of
global high-tech parks, become the core hub of the global innovation and entrepreneurship
network.

Zhongshan Sinobioway Hygene Biomedicine Co., Ltd. was founded in 2004, located in
Zhongshan Torch Development Zone, is a leading genetic engineering
biopharmaceutical enterprise with independent intellectual property rights in China.
Sinobioway Hygene’s main product is Recombinant Human Growth Hormone for
Injection (Somatropin, rhGH), approved by CFDA in 2005.

Anhui Hongye Pharmaceutical Co., Ltd. is a key high-tech enterprise in Bengbu, Anhui
Province, and has advanced production lines for large infusions, oral solutions, drops,
tablets, capsules and APIs and C22-drug production. The Licensed business items are:
production of powder injections (cephalosporins), freeze-dried powder injections, small-
volume injections, tablets, hard capsules, and bulk medicines.